EU_Resp_AimsScope.qxp 7/8/09 3:38 pm Page 2
European Respiratory Disease
Established: October 2005 Current Edition: Volume 5, Issue 1
Aims and Scope
• European Respiratory Disease enables time-pressured physicians to stay abreast of key advances and opinion in respiratory practice in Europe.
• European Respiratory Disease comprises balanced and comprehensive articles written by leading authorities addressing the most important and salient
developments in the field of respiratory disease.
• European Respiratory Disease endeavours to support physicians, clinicians and related healthcare professionals in continuously developing their
knowledge, effectiveness and productivity. The editorial policy has been designed to encourage discussion among this peer group.
• Comprehensive bibliographies for each article mean that European Respiratory Disease is an informative and valuable reference tool for use throughout
the year.
Structure and Format
• European Respiratory Disease is a bi-annual journal comprising review articles, case reports, practice guides, theoretical discussions and
original research.
• The structure of each edition of the publication comprises section categories determined by the Editor. The degree of coverage assigned to
each category is the decision of the Editor, and in part reflects the views of the Editorial Board.
• Articles are fully referenced, providing a comprehensive review of existing knowledge and opinion.
• Each edition of European Respiratory Disease is also replicated in full online at www.touchbriefings.com
Editorial Expertise
European Respiratory Disease is supported by various levels of expertise:
• Guidance from an Editorial Board consisting of leading authorities from a variety of respiratory disciplines.
• Invited contributors are recognised authorities from their respective fields.
• Peer review – conducted by experts appointed for their experience and knowledge of a specific topic.
• An experienced team of Editors and Technical Editors.
Peer Review
• On submission, all articles are assessed by the Editor to determine their suitability for inclusion and appropriateness for peer review.
• The Editor, following consultation with either a member of the Editorial Board or the author(s), identifies appropriate reviewers, who are selected on the
basis of their specialist knowledge in the relevant area.
• Following review, papers are either accepted without modification or returned to the author(s) to incorporate required changes. The Editor reserves the
right to accept or reject any proposed amendments.
Submissions and Instructions to Authors
• Contributors are identified and invited by the Editor with the support of the Technical Editors and guidance from the Editorial Board.
• Following acceptance of an invitation, the author(s) and Editor formalise the working title and scope of the article.
• Subsequently, the Editor provides an ‘Instruction to Authors’ document and additional submission details.
• The Editor is always keen to hear from leading authorities wishing to discuss potential submissions, and will give due consideration to any proposals.
Please contact the Editor for further details. The ‘Instruction to Authors’ information is available for download at www.touchbriefings.com
Reprints
All articles included in European Respiratory Disease are available as reprints (minimum order 1,000).
fergus.brunning@touchbriefings.com or T: +44 (0) 20 7452 5285.
Distribution and Readership
• European Respiratory Disease is distributed bi-annually through controlled circulation to senior professionals in the field.
• European Respiratory Disease is audited by BPA Worldwide.
Subscriptions
European Respiratory Disease is published twice a year and is available on subscription. Subscription rates for 2009 are as follows: Full Institutional
(online and print): €180 (Europe), $225 (the Americas); Full Institutional (online only): €170 (Europe), $210 (the Americas); Full Personal (online and print):
€80 (Europe), $100 (the Americas); Full Personal (online only): €70 (Europe), $85 (the Americas). Professionals working in the respiratory diseases field
qualify for free subscriptions. Further information and an order form are available at www.touchbriefings.com/subscriptions/ or contact Miriam
miriam.oppenheim@touchbriefings.com or T: +44 (0) 20 7452 5135.
Copyright and Permission
Touch Briefings, a Touch Group plc company, is the sole owner of all articles and other materials that appear in European Respiratory Disease, unless
otherwise stated. Permission to reproduce an article, either in full or in part, should be sought from the publication’s Editor.
Online
• www.touchbriefings.com provides clinicians and other industry professionals with a free resource of thousands of articles from over 50 annual and
bi-annual publications, spanning 22 healthcare specialities.
• Available online at www.touchrespiratory disease.com is European Respiratory disease’s sister publication, US Respiratory Disease.
About Touch Briefings
Touch Briefings publishes a rich and diverse portfolio of fully referenced review journals across the clinical and pharmaceutical arenas. Through this
portfolio of over 50 print publications and dedicated industry websites, Touch Briefings aims to assist in the education and practice of healthcare and
pharmaceutical professionals. ■
2
© TOUCH BRIEFINGS 2009